AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Shribact-CV 625 Tablet

Prescription Icon
Prescription Required

Marketer

Shriti Pharmaceutical Private Limited

Salt Composition

Amoxycillin (500mg) + Clavulanic Acid (125mg)

Overview Shribact-CV 625 Tablet

Cefixime 625mg tablets are a bacterial infection fighter. This antibiotic treats lung infections (like pneumonia), ear, sinus, urinary tract, skin, and soft tissue infections. It's ineffective against viral illnesses such as colds. For optimal stomach comfort, take Cefixime 625mg with food. Follow your doctor's prescribed dosage schedule, maintaining consistent intervals. Regular, timed dosing aids in adherence. The prescribed amount varies depending on your condition; always finish the entire course. Premature cessation may allow bacterial survival, potentially leading to relapse or worsening infection. Common side effects, typically mild, include nausea, diarrhea, vomiting, oral or genital yeast infections, skin rashes, and vaginitis. Report persistent or bothersome side effects to your physician. Inform your doctor of any antibiotic allergies, kidney or liver issues, and all other medications you're using, as interactions may occur. Generally considered safe during pregnancy and breastfeeding under medical supervision.

Primary Ingredients of Shribact-CV 625 Tablet

The provided text is "undefined," therefore no rewriting is possible.

Uses of Shribact-CV 625 Tablet

Managing bacterial infections

Major Benefits of Shribact-CV 625 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Administer Shribact-CV 625 Tablet with a meal.

Common Side effects of Shribact-CV 625 Tablet:

  • Vaginal inflammation
  • Mucocutaneous candidiasis
  • Vomiting
  • Nausea
  • Diarrhea
  • Skin rash
  • Red spots or bumps
  • Fungal infection

How to use Shribact-CV 625 Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Shribact-CV 625 Tablet with a meal.

How Shribact-CV 625 Tablet works:

Shribact-CV 625 tablets contain amoxicillin, an antibiotic, and clavulanate potassium, a beta-lactamase inhibitor. Amoxicillin combats bacterial growth by disrupting the formation of their protective cell wall. Clavulanate potassium counteracts bacterial resistance mechanisms, thereby improving amoxicillin's effectiveness.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concurrent use of Shribact-CV 625 Tablet and alcohol.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Shribact-CV 625 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, clinical data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the use of Shribact-CV 625 tablets are compatible. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Shribact-CV 625 Tablet side effects, including allergic reactions, dizziness, or seizures.

KidneyKidneyCAUTION

Patients with kidney impairment should use Shribact-CV 625 Tablets cautiously, potentially requiring dosage modification under medical supervision. This medication is contraindicated in individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Shribact-CV 625 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Liver function should be regularly assessed during treatment.

What if you forget to take Shribact-CV 625 Tablet :

Should you forget a Shribact-CV 625 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Shribact-CV 625 Tablet

LabelValue
Developing Habits No.
Treatment Category Antimicrobial Agents

FAQs on Shribact-CV 625 Tablet

Shribact-CV 625 tablets combine amoxicillin and clavulanic acid to combat various bacterial infections. These infections include tonsillitis, sinusitis, otitis media, respiratory and urinary tract infections, boils, abscesses, cellulitis, wound and bone infections, and oral cavity infections. The medication's mechanism involves eliminating harmful bacteria.
Shribact-CV 625 tablets are generally safe when used as directed, but may cause side effects. These can range from common issues such as diarrhea, nausea, vomiting, and rash to less frequent allergic reactions or other rare effects. Report any persistent problems to your doctor immediately.
Shribact-CV 625 Tablets are contraindicated in patients with penicillin allergies or allergies to any of its components, and should not be taken by those with liver disease. Always inform your doctor of any medication allergies.
Shribact-CV 625 Tablets may reduce the effectiveness of birth control pills. Discuss alternative contraceptive methods (like condoms, diaphragms, or spermicides) with your doctor while taking this medication.
Exceeding the recommended Shribact-CV 625 Tablet dosage raises the risk of side effects. This medication requires time to fully take effect and resolve your infection. For worsening symptoms, seek immediate medical advice.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Don't discontinue Shribact-CV 625 Tablet prematurely, even if you feel better. Symptom improvement doesn't guarantee complete infection resolution. Continue the full course of treatment as prescribed; the medication may still be working.
Shribact-CV 625 Tablets can trigger allergic reactions and should be avoided by individuals with penicillin allergies. Seek immediate medical attention if you experience symptoms such as hives, breathing difficulties, or facial, lip, tongue, or throat swelling.
Shribact-CV 625 Tablets can cause diarrhea, a side effect of its antibiotic action which targets both harmful and beneficial gut bacteria. If diarrhea occurs, increase your fluid intake. Persistent diarrhea or signs of dehydration (infrequent, dark, strong-smelling urine) require immediate medical attention. Do not self-medicate.
Shribact-CV 625 Tablets are ineffective against viral infections such as colds and the flu. Seek medical advice; do not self-medicate.
Shribact-CV 625 Tablets do not cause drowsiness. Report any drowsiness to your doctor.
Shribact-CV 625 Tablet
130